Pharmaceutical Quality · Computerized Systems

CSV in Pharmaceuticals: A Brief Guide to Computerized System Validation

A practical overview of computerized system validation, its lifecycle, core GMP controls, and the records that support a reliable validated state.

Quick answer: What is CSV?

CSV means computerized system validation. In pharmaceutical operations, it is the documented, risk-based work that gives confidence a computerized system is fit for its intended regulated use and remains controlled as it changes. The scope may cover software, hardware, configuration, interfaces, users, procedures, and electronic records. Validation depth should match the system’s intended use and its potential impact on product quality, patient safety, and data integrity.

In this brief guide

1. Why CSV matters
2. Which systems may be in scope?
3. A risk-based CSV lifecycle
4. Core GMP controls and records
5. CSV, Part 11, and Annex 11
6. Practical checklist
7. Frequently asked questions

Why CSV matters in pharmaceuticals

Computerized systems can create, process, review, approve, store, or transmit data used to make quality decisions. An uncontrolled calculation, missing audit trail, incorrect access role, or failed data transfer can affect a laboratory result, batch record, release decision, or regulatory record. CSV helps establish that the system performs its intended functions reliably and that important records remain accurate, complete, retrievable, and protected.

For example, 21 CFR 211.68 addresses controls for automatic, mechanical, and electronic equipment used in drug operations, including authorized changes, checks on data input and output, and backup files. FDA also describes flexible, risk-based strategies for managing data-integrity risks in its Data Integrity and Drug CGMP guidance.

Which systems may be in scope?

Start with intended use, not the product name or vendor label. Examples include systems used for regulated records, laboratory testing, manufacturing, quality review, or controlled storage.

System example	Possible GxP use	Risk questions
LIMS or chromatography data system	Sample control, calculations, chromatograms, results, and review	Are raw data, processing methods, audit trails, and reports preserved?
MES, electronic batch record, or ERP	Manufacturing instructions, material status, batch history, and disposition	Are recipe changes, user actions, interfaces, and approvals controlled?
eQMS or document system	Deviations, CAPA, change control, SOPs, training, and approvals	Are versions, signatures, access, and retention reliable?
Spreadsheet, instrument, or utility control system	GxP calculations, records, environmental monitoring, or process control	Could an error or unauthorized change affect a quality decision?

Scope principle: Inventory systems first, then document each system’s intended use, GxP role, data flows, interfaces, owners, and risk classification. A system with no regulated function may need IT controls but not the same validation package as a system that makes or records a GMP decision.

A risk-based CSV lifecycle

CSV is a lifecycle activity rather than a one-time test before go-live. The deliverables below are common examples; each organization should scale them to risk, system type, and applicable requirements.

1. Define intended use and ownership. Identify the process, records, users, system boundary, interfaces, and process/system owners. Translate process needs into clear, testable requirements in a URS.
2. Assess risk and supplier evidence. Evaluate potential impact on product quality, patient safety, and data integrity; consider complexity, configuration, access, interfaces, and failure modes. Assess supplier documentation and services, then justify the validation effort from the risks identified.
3. Design or configure the system. Review whether the design and configuration meet approved requirements. Where appropriate, document design review or DQ before installation.
4. Qualify and test intended functions. Test requirements, calculations, limits, user roles, audit trails, electronic signatures, interfaces, error handling, and reports according to risk. Evidence may include IQ, OQ, or PQ activities where they suit the system. Not every system needs identical phases or paperwork.
5. Approve for use and train users. Resolve test exceptions, document deviations, approve the validation summary, release the system through Quality procedures, and ensure users are trained before regulated use. Link system operation to effective SOPs.
6. Maintain the validated state. Use change control for upgrades, configuration changes, new interfaces, and migrations. Review incidents and periodic-review results, confirm backup and restore capability, and control archiving or retirement. Address systemic failures through investigation and CAPA when warranted.

Risk-based validation is compatible with cGMP; it means that test scope and evidence are justified, not that critical functions are left unverified. Document records in line with ALCOA+ principles.

Core GMP controls and records

Control area	What to establish	Useful evidence
Access and roles	Authorized, individual access; role permissions match job duties; prompt access removal	Approved access matrix, account review, user training records
Data and audit trail	Reliable capture, review, and retention of relevant original records and changes	Risk-based tests, audit-trail review procedure, sample records
Calculations and interfaces	Verify critical inputs, outputs, calculations, transfers, and exception handling	Test cases, expected results, reconciliation or interface checks
Electronic signatures	Where applicable, link signatures to records and define signature meaning and accountability	Signature configuration and user acceptance tests
Backup, restore, and retention	Protect records and demonstrate they can be restored and remain readable for the required retention period	Backup schedule, restore test, retention and archive procedure
Change and incident control	Assess impact before changes; investigate failures; retest affected functions	Change records, incident investigations, regression tests, CAPA

For systems used to maintain regulated records, written procedures should define record review, exception handling, backup, restoration, retention, and user responsibilities. The supporting records should be attributable, legible, contemporaneous, original or verified copies, and accurate; see the site’s ALCOA+ data integrity guide.

CSV, 21 CFR Part 11, and EU Annex 11

CSV and Part 11 are related but not interchangeable. CSV documents that a system is fit for its intended regulated use. 21 CFR Part 11 sets criteria for certain electronic records and electronic signatures. Its applicability depends on the records and signatures involved and the underlying regulatory recordkeeping requirements; FDA’s Part 11 Scope and Application guidance explains FDA’s approach. See also the site’s overview of 21 CFR regulations for pharmaceuticals.

For the European Union, consult the applicable version of EudraLex Volume 4, Annex 11: Computerised Systems. Requirements differ by market and system use. FDA’s Part 11 guidance is nonbinding; the regulation and applicable predicate rules remain important. Have Quality and regulatory specialists determine applicability for each system and record type.

Remember: A vendor certificate or successful installation is not, by itself, evidence that the configured system is suitable for your process. The regulated organization remains responsible for its intended use, controls, and records.

Practical CSV checklist

• Is the system inventoried, its intended use defined, and ownership assigned?
• Are GxP impact and data-integrity risks documented and used to set test depth?
• Do requirements map to design/configuration and executed tests?
• Are users, roles, audit trails, calculations, interfaces, and signatures tested where relevant?
• Are deviations resolved and the release decision approved before regulated use?
• Are SOPs, training, backup/restore, retention, and periodic review in place?
• Are upgrades, incidents, migrations, and retirement managed through controlled procedures?

Frequently asked questions

What does CSV stand for in pharma?

CSV stands for computerized system validation: documented evidence that a system is fit for its intended regulated use and remains under control.

Do all computer systems need full CSV?

No. First assess intended use and GxP impact. Apply controls and validation proportionate to documented risks and applicable requirements.

Is CSV the same as 21 CFR Part 11?

No. CSV covers system fitness for intended use. Part 11 addresses certain electronic records and signatures in its scope, alongside applicable predicate rules.

How often should a validated system be revalidated?

There is no single interval for every system. Reassess after changes, incidents, and periodic reviews; perform testing needed to show affected functions remain controlled.

References and further reading

1. Electronic Code of Federal Regulations, 21 CFR Part 11 — electronic records and electronic signatures.
2. Electronic Code of Federal Regulations, 21 CFR 211.68 — automatic, mechanical, and electronic equipment used in drug operations.
3. FDA, Part 11 Scope and Application — FDA’s nonbinding guidance on Part 11 scope.
4. FDA, Data Integrity and Compliance With Drug CGMP: Questions and Answers.
5. European Commission, EudraLex Volume 4, Annex 11 — Computerised Systems.